Xiaojian Dai

476 total citations
27 papers, 404 citations indexed

About

Xiaojian Dai is a scholar working on Pharmacology, Oncology and Analytical Chemistry. According to data from OpenAlex, Xiaojian Dai has authored 27 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 6 papers in Oncology and 6 papers in Analytical Chemistry. Recurrent topics in Xiaojian Dai's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Analytical Methods in Pharmaceuticals (6 papers) and Cancer Treatment and Pharmacology (4 papers). Xiaojian Dai is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Analytical Methods in Pharmaceuticals (6 papers) and Cancer Treatment and Pharmacology (4 papers). Xiaojian Dai collaborates with scholars based in China and Brazil. Xiaojian Dai's co-authors include Xiaoyan Chen, Dafang Zhong, Cen Xie, Zhiwei Gao, Haoyuan Jiang, Liang Li, Lijia Zhang, Pan Deng, Ke Liu and Xiaotao Duan and has published in prestigious journals such as Clinical Pharmacokinetics, Drug Metabolism and Disposition and Obesity Surgery.

In The Last Decade

Xiaojian Dai

25 papers receiving 392 citations

Peers

Countries citing papers authored by Xiaojian Dai

Since Specialization

Citations

This map shows the geographic impact of Xiaojian Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojian Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojian Dai more than expected).

Fields of papers citing papers by Xiaojian Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojian Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojian Dai. The network helps show where Xiaojian Dai may publish in the future.

Co-authorship network of co-authors of Xiaojian Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojian Dai. A scholar is included among the top collaborators of Xiaojian Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojian Dai. Xiaojian Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Qualitative and quantitative determination of anaprazole and its major metabolites in human plasma 2020 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Liang Li, (unknown), Jin Wang, Bo Chen, Xiaojian Dai, Yifan Zhang, Xiaoyan Chen	6
2	<p>Bioequivalence of paclitaxel protein-bound particles in patients with breast cancer: determining total and unbound paclitaxel in plasma by rapid equilibrium dialysis and liquid chromatography–tandem mass spectrometry</p> 2019 ·Drug Design Development and Therapy ·Junling Li, Wěi Li, Xiaojian Dai, Dafang Zhong, Yaping Ding, Xiaoyan Chen	5
3	Simultaneous determination of imrecoxib and its two active metabolites in plasma of hepatic impairment patients by liquid chromatography-tandem mass spectrometry 2019 ·Journal of Chromatography B ·Xiang‐Yu Hou, Xiaojian Dai, Yong Yang, Yifan Zhang, Dafang Zhong, Xiaoyan Chen	2
4	Mechanism of Reductive Metabolism and Chiral Inversion of Proton Pump Inhibitors 2019 ·Drug Metabolism and Disposition ·(unknown), Zhaoqiang Chen, Xiaojian Dai, Weiliang Zhu, Dafang Zhong, Xiaohong Chen	2
5	Increased Serum IGFBP-1 and Reduced Insulin Resistance After Roux-En-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes: a 6-Month Follow-Up 2018 ·Obesity Surgery ·(unknown), Xiaojian Dai, Hao Yu, Qing Luo, (unknown), (unknown)	9
6	Effect of <em>N</em>-methyl deuteration on metabolism and pharmacokinetics of enzalutamide 2016 ·Drug Design Development and Therapy ·Jinfang Jiang, Xuehai Pang, Xiaojian Dai, Xingxing Diao, Xiaoyan Chen, Dafang Zhong, Yuanwei Chen, Liang Li, Yingwei Wang	29
7	[Determination of anaprazole in human plasma by LC-MS/MS in pharmacokinetic study]. 2016 ·PubMed ·(unknown), Xiaojian Dai, Yifan Zhang, (unknown), (unknown), (unknown), Jin Li, Xiaohong Chen, Dafang Zhong	2
8	Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers 2016 ·Drug Design Development and Therapy ·Yifan Zhang, Xiaojian Dai, Yong Yang, Xiaoyan Chen, Ting Wang, (unknown), Cheng‐Yuan Tsai, Li‐Wen Chang, Yu‐Ting Chang, Dafang Zhong	4
9	Simultaneous determination of capecitabine and its three nucleoside metabolites in human plasma by high performance liquid chromatography–tandem mass spectrometry 2015 ·Journal of Chromatography B ·Pan Deng, Ji Cheng, Xiaojian Dai, Dafang Zhong, Li Ding, Xiaoyan Chen	32
10	Effects of an Al3+- and Mg2+-containing antacid, ferrous sulfate, and calcium carbonate on the absorption of nemonoxacin (TG-873870) in healthy Chinese volunteers 2014 ·Acta Pharmacologica Sinica ·Yifan Zhang, Xiaojian Dai, Ting Wang, Xiaoyan Chen, Liang Li, (unknown), Cheng‐Yuan Tsai, Li‐Wen Chang, (unknown), (unknown), Yu‐Ting Chang, (unknown), Dafang Zhong	6
11	Simultaneous determination of apatinib and its four major metabolites in human plasma using liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study 2012 ·Journal of Chromatography B ·(unknown), Xiaoyan Chen, Xiaojian Dai, Dafang Zhong	41
12	Simultaneous determination of dronedarone and its active metabolite debutyldronedarone in human plasma by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study 2011 ·Journal of Chromatography B ·Cen Xie, (unknown), Dafang Zhong, Xiaojian Dai, Xiaoyan Chen	26
13	Pharmacokinetics of tacrolimus converted from twice-daily formulation to once-daily formulation in Chinese stable liver transplant recipients 2011 ·Acta Pharmacologica Sinica ·Yifan Zhang, Xiaoyan Chen, Xiaojian Dai, Xi-sheng Leng, Dafang Zhong	4
14	Liquid chromatography/tandem mass spectrometry method for the quantification of deserpidine in human plasma: Application to a pharmacokinetic study 2009 ·Journal of Chromatography B ·Huaicheng Zhang, Dafang Zhong, Zhenzhong Zhang, Xiaojian Dai, Xiaohong Chen	7
15	Simultaneous determination of 6R-leucovorin, 6S-leucovorin and 5-methyltetrahydrofolate in human plasma using solid phase extraction and chiral liquid chromatography–tandem mass spectrometry 2009 ·Journal of Chromatography B ·Ke Liu, Xiaojian Dai, Dafang Zhong, Pan Deng, (unknown), Xiaoyan Chen	13
16	Quantitative determination of ondansetron in human plasma by enantioselective liquid chromatography-tandem mass spectrometry 2008 ·Journal of Chromatography B ·Ke Liu, Xiaojian Dai, Dafang Zhong, Xiaoyan Chen	29
17	Rapid and selective liquid chromatographic/tandem mass spectrometric method for the determination of fosfomycin in human plasma 2007 ·Journal of Chromatography B ·Li Li, Xiaoyan Chen, Xiaojian Dai, (unknown), Dafang Zhong	28
18	Influence of omeprazole on pharmacokinetics of domperidone given as free base and maleate salt in healthy Chinese patients 2007 ·Acta Pharmacologica Sinica ·(unknown), Xiaoyan Chen, Xiaojian Dai, (unknown), Qizhi Liu, (unknown), Dafang Zhong	7
19	Application of a sensitive liquid chromatographic/tandem mass spectrometric method to pharmacokinetic study of nalmefene in humans 2007 ·Journal of Chromatography B ·Ping Li, Xiaoyan Chen, Xiaojian Dai, Aidong Wen, Yifan Zhang, Dafang Zhong	4
20	Development and validation of a liquid chromatographic/tandem mass spectrometric method for the determination of sertraline in human plasma 2006 ·Rapid Communications in Mass Spectrometry ·Xiaoyan Chen, Xiaotao Duan, Xiaojian Dai, Dafang Zhong	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact